Subscribe to our newsletter

Like to be kept up to date? Sign up to our bi-monthly newsletter here!

Related articles

Guidelines: Safe-by-desig... A novel guideline document elaborated by the EU-consortium GoNanoBioMat and presented at the final dissemination event. The GoNanoBioMat framework is designed to elaborate current knowledge to small and medium-sized enterprises
Pigments are Nano A webinar by Nanomaterials are something new and innovative, right? Not necessarily: Certain nanomaterials were already in use in the Stone Age, long before mankind invented
Nanomedicine: The Minuten... Tiny particles that can fight cancer or that can easily pass through any interface within our body are a great promise for medicine. But there is little
Publications on Synthetic... Action plan Synthetic Nanomaterials Final report 2 September 2020 (only available in German and French) Opportunities and Risks of Nanomaterials Journal of Nanobiotechnology, 2017 Opportunities and Risks
Safe-by-design and EU fun... Contribution of the EU NanoSafetyCluster (NSC), supporting the SbD-study of the European Commission, March 2021 Editors: Andreas Falk, Flemming R. Cassee and Eva Valsami-Jones
Need help with the regist... eREACHNano is a new free web tool focused on helping small and medium-sized companies that may lack sufficient in-house expertise on the regulation covering nanomaterials.
Developing trends in nano... Waste containing nanomaterials — or nanowaste — is an emerging safety concern worldwide, warranting specific environmentally sound waste management and regulation. Authors: Arturo A. Keller, Alex Ehrens, Yuanfang Zheng & Bernd
Crucial results for coron... Empa researcher Peter Wick, Head of the Particles-Biology Interactions Laboratory in St. Gallen and Director of talks to Empa Quarterly about recent antibody studies, which are
Microplastics and Nanopla... Recently, the European Commission published a study that provides further information on the intentional uses of microplastic particles in products and the risks they pose to human
The MACRAMÉ Project, a 36-months research and innovation action, funded by the European Commission’s Horizon Europe Framework Programme, commenced its ambitious, collaborative workprogramme on the characterisation and